ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis
Authors:
- Gregory P. ArutyunovGAGregory P. Arutyunov
- Ekaterina I. TarlovskayaETEkaterina I. Tarlovskaya
- Alexander G. ArutyunovAAAlexander G. Arutyunov
- Yuri N. BelenkovYBYuri N. Belenkov
- Alexandra O. KonradiAKAlexandra O. Konradi
- Yury M. LopatinYLYury M. Lopatin
- Andrey P. RebrovARAndrey P. Rebrov
- Sergey N. TereshchenkoSTSergey N. Tereshchenko
- Anna I. ChesnikovaACAnna I. Chesnikova
- Hamlet G. HayrapetyanHHHamlet G. Hayrapetyan
- Aleksandr P. BabinABAleksandr P. Babin
- Igor G. BakulinIBIgor G. Bakulin
Open Access
- 15 January 2022
- journal article
- research article
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 94 (1) , 32-47
Abstract
Aim. Study the impact of various combinations of comorbid original diseases in patients infected with COVID-19 later on the disease progression and outcomes of the new coronavirus infection. Materials and methods. The ACTIV registry was created on the Eurasian Association of Therapists initiative. 5,808 patients have been included in the registry: men and women with COVID-19 treated at hospital or at home. ClinicalTrials.gov ID NCT04492384. Results. Most patients with COVID-19 have original comorbid diseases (oCDs). Polymorbidity assessed by way of simple counting of oCDs is an independent factor in negative outcomes of COVID-19. Search for most frequent combinations of 2, 3 and 4 oCDs has revealed absolute domination of cardiovascular diseases (all possible variants). The most unfavorable combination of 2 oCDs includes atrial hypertension (AH) and chronic heart failure (CHF). The most unfavorable combination of 3 oCDs includes AH, coronary heart disease (CHD) and CHF; the worst combination of 4 oCDs includes AH, CHD, CHF and diabetes mellitus. Such combinations increased the risk of lethal outcomes 3.963, 4.082 and 4.215 times respectively. Conclusion. Polymorbidity determined by way of simple counting of diseases may be estimated as a factor in the lethal outcome risk in the acute phase of COVID-19 in real practice. Most frequent combinations of 2, 3 and 4 diseases in patients with COVID-19 primarily include cardiovascular diseases (AH, CHD and CHF), diabetes mellitus and obesity. Combinations of such diseases increase the COVID-19 lethal outcome risk.Keywords
This publication has 25 references indexed in Scilit:
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, ChinaJAMA Cardiology, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Hypolipidemia is associated with the severity of COVID-19Journal of Clinical Lipidology, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Multimorbidity in General Practice: Prevalence, Incidence, and Determinants of Co-Occurring Chronic and Recurrent DiseasesJournal of Clinical Epidemiology, 1998
- Comorbidity or multimorbidityEuropean Journal of General Practice, 1996
- Statistical issues in assessing comorbidityStatistics in Medicine, 1995
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987